Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith O'Shea

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Reproductive Health Matters|November 26, 2008
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implicationsSue J Goldie, Meredith O'Shea, Mireia Diaz, et al.
Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan AfricaJane J Kim, Nicole G Campos, Meredith O'Shea, et al.
Vaccine|June 14, 2008
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesSue J Goldie, Meredith O'Shea, Nicole Gastineau Campos, et al.
Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)Jane J Kim, Monisha Sharma, Meredith O'Shea, et al.
Vaccine|July 8, 2008
Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policyJane J Kim, Katie E Kobus, Mireia Diaz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2010
Cost-effectiveness of human papillomavirus vaccination and screening in SpainMireia Diaz, Silvia de Sanjose, Jesse Ortendahl, et al.
International Journal of Cancer|July 1, 2011
Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern AfricaNicole G Campos, Jane J Kim, Philip E Castle, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|February 2, 2013
Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in PeruSue J Goldie, Carol Levin, N Rocio Mosqueira-Lovón, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Reproductive Health Matters|November 26, 2008
Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implicationsSue J Goldie, Meredith O'Shea, Mireia Diaz, et al.
Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in sub-Saharan AfricaJane J Kim, Nicole G Campos, Meredith O'Shea, et al.
Vaccine|June 14, 2008
Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countriesSue J Goldie, Meredith O'Shea, Nicole Gastineau Campos, et al.
Vaccine|December 17, 2013
Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA)Jane J Kim, Monisha Sharma, Meredith O'Shea, et al.
Vaccine|July 8, 2008
Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policyJane J Kim, Katie E Kobus, Mireia Diaz, et al.
European Journal of Cancer (Oxford, England : 1990)|July 20, 2010
Cost-effectiveness of human papillomavirus vaccination and screening in SpainMireia Diaz, Silvia de Sanjose, Jesse Ortendahl, et al.
International Journal of Cancer|July 1, 2011
Health and economic impact of HPV 16/18 vaccination and cervical cancer screening in Eastern AfricaNicole G Campos, Jane J Kim, Philip E Castle, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|February 2, 2013
Health and economic impact of human papillomavirus 16 and 18 vaccination of preadolescent girls and cervical cancer screening of adult women in PeruSue J Goldie, Carol Levin, N Rocio Mosqueira-Lovón, et al.
Pageof 1